In this episode, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, review two major developments in diabetes care: the forthcoming 15-day Dexcom G7 continuous glucose monitor (CGM) and significant new price reductions for semaglutide as Ozempic and Wegovy.



Key Episode Timestamps

00:00:01 Introduction

00:00:30 Dexcom G7

00:01:55 A 15-Day Sensor With a 12-Hour Grace Period

00:04:27 Seamless transition to the new G7

00:05:23 Looking back at Dexcom's advancements

00:06:34 Dexcom's Smart Basal feature

00:10:34 Price cuts for semaglutide - Wegovy and Ozempic

00:14:54 Cheaper GLP-1s on the pharmacies' end

00:20:33 Outro